August 23, 2022 Corporate and Business News

• BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical trial in France for its novel gene therapy for early-stage Huntington's Disease

• Wemade Holds the 1st Anniversary Event of MIR4 Global Service!

• BerGenBio reports second quarter and half year 2022 financial results and provides business update

• Back to Home

• Archive History